Literature DB >> 35114127

New EU regulation on health technology assessment of cancer medicines.

Thomas J Hwang1, Kerstin N Vokinger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35114127     DOI： 10.1016/S1470-2045(22)00008-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021.

Authors:  Kerstin N Vokinger; Aaron S Kesselheim; Camille E G Glaus; Thomas J Hwang
Journal:  JAMA Health Forum       Date:  2022-08-05

Review 2.  Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments.

Authors:  Dario Trapani; Kiu Tay-Teo; Megan E Tesch; Felipe Roitberg; Manju Sengar; Sara C Altuna; Michael J Hassett; Armando A Genazzani; Aaron S Kesselheim; Giuseppe Curigliano
Journal:  Curr Oncol       Date:  2022-08-16       Impact factor: 3.109
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.